Sanofi Consumer Healthcare India valuation

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Dec 2025FY25Dec 2024
Price multiples — at each FY-end close
27.32×——
19.90×——
7.81×——
28.33×——
Enterprise multiples
7.42×——
19.66×——
20.38×——
Yield
3.7%——
3.5%——
Reference — adjusted share basis
₹3,322.80——
₹121.61₹104.39₹78.70
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SANOFICONR₹3,322.80

Sanofi Consumer Healthcare India Limited

· Pharma & Health
₹ CrorePeersPGHLSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹7,642 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY25
31/12/2024
FY26
31/12/2025
Current/LTM
TTM · last close
Price Multiples — at each FY-end close
P/E——27.32
P/B——19.90
P/Sales——7.81
Price to Free Cash Flow——28.33
Enterprise Multiples
EV/Sales——7.42
EV/EBITDA——19.66
EV/EBIT——20.38
Yield
Earnings Yield %——3.66
FCF Yield %——3.53
Reference — adjusted share basis
Price (FY-end close, adj.)——3,322.80
EPS (adj.)78.70104.39121.61
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.